European Startups raised capital in order to expand and move into more successful. Here is this week's Top European Startups Funding Roundup - January 6 – January 10 2025.
SUMMARY
- Top Funding Wrap of the Week – January 6 – January 10 2025
- Verdiva Bio, Smartfin, FIRE1, CeQur, XOCEAN, Orbis Medicines, Leyden Labs, Numab Therapeutics, Superhero Capital ,Hycamite, are the top 10 European Startups Funding Roundup in This Week.
The Top 10 European Startups Funding Roundup of This Week
Verdiva Bio
Verdiva Bio Limited (“Verdiva” or “the Company”) announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders.
Smartfin
Smartfin, a leading growth equity investor in European B2B technology companies, has successfully closed its third growth fund at its €250 million target.
FIRE1
FIRE1, a company that provides connected medical device solutions, has raised $120M in funding, led by Polaris Partners and Elevage Medical Technologies. New investors like Longitude Capital and Sands Capital joined existing investors in this round.
CeQur
CeQur, a company that makes medical devices for easier insulin delivery, has raised $120 million.
XOCEAN
Ireland-based XOCEAN, which provides ocean data for offshore energy and civil hydrography sectors, has raised €115M in funding to expand globally.
Orbis Medicines
Orbis Medicines, a leader in oral macrocycle drug discovery, announces the close of a €90Million Series A funding round, bringing the total amount raised by the company to EUR 116 million. The funds will support the development of Orbis’ pipeline of next-generation oral macrocycle drugs, called ‘nCycles.’
Leyden Labs
Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) announced it has raised $70M in funding to advance its Mucosal Protection Platform.
Numab Therapeutics
Numab Therapeutics AG , a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibodies in immunology and oncology, announced today the closing of an oversubscribed CHF 50 million (approximately USD 55 million) Series C extension, bringing the total Series C to CHF 180 million.
Superhero Capital
Helsinki-based Superhero Capital has launched its fourth fund, focusing on investments in Finland and the Baltics. The firm has typically invested up to €1 million in each project.
Hycamite
Hycamite TCD Technologies (“Hycamite”) has attracted strong global interest in its methane-splitting technology, which produces low-carbon hydrogen and high-value solid carbon products from methane.